Emilie Estrabaud
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Effectiveness and Safety of Lenacapavir-Containing Regimens in Highly Experienced HIV-Infected Patients With Multidrug Resistance: Real-world Results From the French Compassionate Use Program a.
Journal: Open forum infectious diseases
Published: April 29, 2026
Recent advances in hepatology.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: January 05, 2017
Precore/Core promoter variants to predict significant fibrosis in both HBeAg positive and negative chronic hepatitis B.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: October 31, 2014
IFI35, mir-99a and HCV genotype to predict sustained virological response to pegylated-interferon plus ribavirin in chronic hepatitis C.
Journal: PloS one
Published: October 17, 2014
Reduction of microRNA 122 expression in IFNL3 CT/TT carriers and during progression of fibrosis in patients with chronic hepatitis C.
Journal: Journal of virology
Published: March 28, 2014
IFNL3 expression and response to treatment: behind the HCV tricks.
Journal: Journal of hepatology
Published: March 12, 2014
IFNL3 (IL28B) polymorphism does not predict long-term response to interferon therapy in HBeAg-positive chronic hepatitis B patients.
Journal: Journal of viral hepatitis
Published: May 01, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026